The Novo Nordisk symposium ‘A change of heart – why cardiologists can’t ignore semaglutide’ at the ESC Congress 2025 will feature speakers Tina Vilsbøll, Nikolaus Marx, Mark Petrie and Mikael Rydén. This symposium will discuss the burden of CVD in people living with overweight and obesity, explore current treatment options for people living with overweight and obesity, present key findings from the STEP-HFpEF and SELECT trials and finally explore clinical considerations.
Add to Calendar
Download agenda
Sunday, 31 August 2025
12:30 - 12:39
(CEST)
Welcome & introduction
Tina Vilsbøll, Nikolaus Marx
12:39 - 12:49
(CEST)
A STEP towards connecting HFpEF and obesity care
Mark Petrie
12:49 - 13:02
(CEST)
Obesity and CVD care: Targeting the cardiometabolic axis
Nikolaus Marx
13:02 - 13:15
(CEST)
Beyond weight loss: Integrating evidence into clinical practice
Mikael Rydén
13:15 - 13:30
(CEST)
Panel discussion and Q&A
Tina Vilsbøll, Mark Petrie, Nikolaus Marx, Mikael Rydén